Company profile
Axonis Therapeutics
Axonis Therapeutics is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders
- Industry
- Biotechnology
- Employees
- 26
- Headquarters
- Boston, Massachusetts
- Founded
- 2019
- LinkedIn followers
- 5,945
- Office locations
- 2
Axonis Therapeutics company summary
Axonis Therapeutics is a company in the Biotechnology industry, headquartered in Boston, Massachusetts, founded in 2019. On LinkedIn the company has around 26 employees and 5,945 followers. The company lists 2 office locations. Its listed specialties include Biotechnology, Drug Discovery, Neuroregeneration, Neuromodulation, Neuroprotection.
What technology does Axonis Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Axonis Therapeutics
Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibitory neurotransmission within the brain, by translating breakthrough discoveries spun out from Boston Children’s Hospital, Harvard and Laval University. The company has built a proprietary KCC2 discovery engine, based on several years of world-leading know-how, to become the leaders in this potentially blockbuster drug space. Axonis’ lead development candidate, AXN-027 is a first-in-class oral small molecule designed to potentiate the function of KCC2, a major CNS chloride transporter essential for inhibitory neurotransmission, for the treatment of epilepsy and pain. Axonis recently closed a $115 Million Series A financing co-led by Cormorant Asset Management and venBio Partners with significant investments from Sofinnova Investments, MRL Ventures Fund (Merck & Co., Rahway, NJ), Perceptive Advisors, Solasta Ventures and Lumira Ventures. Axonis is grateful for grant awards received from NIH, DoD, Wings for Life, MLSC, Praxis SCI, CURE Epilepsy, ISSNL and SynGAP Foundation. The company is headquartered in Boston, MA. For more information, visit www.axonis.us.
Specialties
Where is Axonis Therapeutics located?
Axonis Therapeutics lists 2 office locations.
Compare companies similar to Axonis Therapeutics
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Axonis Therapeutics axonis.us | Biotechnology | 26 | 2019 | Boston, Massachusetts |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Axonis Therapeutics
What does Axonis Therapeutics do?
Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibitory neurotransmission within the brain, by translating breakthrough discoveries spun out from Boston Children’s Hospital, Harvard and Laval University. The company has built a proprietary KCC2 discovery engine, based on several years of world-leading know-how, to become the leaders in this potentially blockbuster drug space. Axonis’ lead development candidate, AXN-027 is a first-in-class oral small molecule designed to potentiate the function of KCC2, a major CNS chloride transporter essential for inhibitory neurotransmission, for the treatment of epilepsy and pain. Axonis recently closed a $115 Million Series A financing co-led by Cormorant Asset Management and venBio Partners with significant investments from Sofinnova Investments, MRL Ventures Fund (Merck & Co., Rahway, NJ), Perceptive Advisors, Solasta Ventures and Lumira Ventures. Axonis is grateful for grant awards received from NIH, DoD, Wings for Life, MLSC, Praxis SCI, CURE Epilepsy, ISSNL and SynGAP Foundation. The company is headquartered in Boston, MA. For more information, visit www.axonis.us.
How many employees does Axonis Therapeutics have?
Axonis Therapeutics has around 26 employees on LinkedIn.
Where is Axonis Therapeutics headquartered?
Axonis Therapeutics is headquartered in Boston, Massachusetts.
Where does Axonis Therapeutics have offices?
Axonis Therapeutics lists 2 office locations, including Boston, Massachusetts, US; Cambridge, MA, US.
When was Axonis Therapeutics founded?
Axonis Therapeutics was founded in 2019.
Build a lead list from companies like Axonis Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.